Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Cellular Biomedicine Group (CBMG) News Today

Cellular Biomedicine Group logo
Intra-Cellular price target raised to $89 from $81 at JPMorgan
Intra-Cellular announces results from Study 304 on lumateperone
Intra-Cellular price target raised to $119 from $113 at Canaccord
Do You Really Need a GPS + Cellular Apple Watch?
Peaking Back In On Intra-Cellular Therapies
Idea Cellular earnings preview: what to expect
T Mobile to acquire US Cellular for $4.4bn
Get Cellular Biomedicine Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CBMG and its competitors with MarketBeat's FREE daily newsletter.

Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 

CBMG Media Mentions By Week

CBMG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CBMG
News Sentiment

0.00

0.47

Average
Medical
News Sentiment

CBMG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CBMG Articles
This Week

0

2

CBMG Articles
Average Week

Get Cellular Biomedicine Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CBMG and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CBMG) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners